InsidersTradesSigma
Follow the 엑세스바이오 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 엑세스바이오 has recorded 9 public disclosures. The latest transaction was reported on 29 January 2026 (Purchase). Among the most active insiders: 팜젠사이언스. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
9 of 9 declarations
Access Bio is in the health and pharmaceutical sector, listed on the XKRX market. The company specializes in the development of medical diagnostics and health technologies.